Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies
Open Access
- 8 June 2021
- journal article
- review article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 22 (5) , 1-23
Abstract
Middle East respiratory syndrome (MERS) is a lethal respiratory disease with its first case reported back in 2012 (Jeddah, Saudi Arabia). It is a novel, siKeywords
This publication has 286 references indexed in Scilit:
- Middle East Respiratory Syndrome Coronavirus in Bats, Saudi ArabiaEmerging Infectious Diseases, 2013
- Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine CandidatemBio, 2013
- Close Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat, South AfricaEmerging Infectious Diseases, 2013
- Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapyInternational Journal of Infectious Diseases, 2013
- Middle East Respiratory Syndrome-coronavirus infection: An overviewJournal of Infection and Public Health, 2013
- Middle East Respiratory Syndrome Coronavirus Infections in Health Care WorkersNew England Journal of Medicine, 2013
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatmentJournal of General Virology, 2013
- The Struggle Against MERS-CoV (The Novel Coronavirus)Oman Medical Journal, 2013
- Prediction of Intrinsic Disorder in MERS-CoV/HCoV-EMC Supports a High Oral-Fecal TransmissionPLoS Currents, 2013
- State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in HumansPLoS Currents, 2013